Literature DB >> 28407379

Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.

Marie-Emilie Francart1, Justine Lambert1, Aline M Vanwynsberghe1, Erik W Thompson2, Morgane Bourcy1, Myriam Polette3, Christine Gilles1.   

Abstract

Epithelial-mesenchymal transitions (EMTs) associated with metastatic progression may contribute to the generation of hybrid phenotypes capable of plasticity. This cellular plasticity would provide tumor cells with an increased potential to adapt to the different microenvironments encountered during metastatic spread. Understanding how EMT may functionally equip circulating tumor cells (CTCs) with an enhanced competence to survive in the bloodstream and niche in the colonized organs has thus become a major cancer research axis. We summarize here clinical data with CTC endpoints involving EMT. We then review the work functionally linking EMT programs to CTC biology and deciphering molecular EMT-driven mechanisms supporting their metastatic competence. Developmental Dynamics 247:432-450, 2018.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CTC; EMP; EMT; coagulation; early metastasis

Mesh:

Year:  2017        PMID: 28407379     DOI: 10.1002/dvdy.24506

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  34 in total

1.  Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.

Authors:  Ian MacFawn; Hannah Wilson; Luke A Selth; Ian Leighton; Ilya Serebriiskii; R Christopher Bleackley; Osama Elzamzamy; Joshua Farris; Phillip M Pifer; Jennifer Richer; Steven M Frisch
Journal:  Mol Immunol       Date:  2018-11-30       Impact factor: 4.407

2.  11th International Symposium on Minimal Residual Cancer (ISMRC): 3-5 May 2018, Montpellier, France.

Authors:  Catherine Alix-Panabières; Klaus Pantel
Journal:  Clin Exp Metastasis       Date:  2018-07-06       Impact factor: 5.150

Review 3.  Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?

Authors:  Jente van Staalduinen; David Baker; Peter Ten Dijke; Hans van Dam
Journal:  Oncogene       Date:  2018-07-12       Impact factor: 9.867

4.  Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.

Authors:  Anthony Tachtsidis; Anh Viet-Phuong Le; Tony Blick; Devika Gunasinghe; Emma De Sousa; Mark Waltham; Alex Dobrovic; Erik W Thompson
Journal:  Clin Exp Metastasis       Date:  2019-06-12       Impact factor: 5.150

Review 5.  Inflammation and Cancer: Triggers, Mechanisms, and Consequences.

Authors:  Florian R Greten; Sergei I Grivennikov
Journal:  Immunity       Date:  2019-07-16       Impact factor: 31.745

Review 6.  Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal.

Authors:  Alexios-Fotios A Mentis; Petros D Grivas; Efthimios Dardiotis; Nicholas A Romas; Athanasios G Papavassiliou
Journal:  Cell Mol Life Sci       Date:  2020-04-24       Impact factor: 9.261

7.  The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study.

Authors:  Su Yan; Wenyi Guo; Yanliang Liu; Kai Li; Weixing Wang
Journal:  Int J Clin Oncol       Date:  2022-01-19       Impact factor: 3.402

8.  Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition.

Authors:  Zhaotao Wang; Zhi Liu; Guoyong Yu; Xiaohu Nie; Weiqiang Jia; Ru-En Liu; Ruxiang Xu
Journal:  Neurochem Res       Date:  2018-02-08       Impact factor: 3.996

Review 9.  Controversies around epithelial-mesenchymal plasticity in cancer metastasis.

Authors:  Elizabeth D Williams; Dingcheng Gao; Andrew Redfern; Erik W Thompson
Journal:  Nat Rev Cancer       Date:  2019-10-30       Impact factor: 60.716

Review 10.  Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells.

Authors:  Maxim E Menyailo; Ustinia A Bokova; Elena E Ivanyuk; Anna A Khozyainova; Evgeny V Denisov
Journal:  Mol Diagn Ther       Date:  2021-07-21       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.